Qingzhou Capital
Overview
Qingzhou Capital is a venture capital firm based in Beijing that specializes in early-stage investments in hard technology sectors, including semiconductors, aerospace, medical technology, and new energy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NeuroXess | Dec 2022 | Series A | Co-investor |
| Hangzhou Huiwei Intelligent Medical Technology | Dec 2022 | Series A | Co-investor |
| KingTiger Technology | Aug 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Qingzhou Capital based?
Qingzhou Capital is headquartered in Beijing, China.
When was Qingzhou Capital founded?
Qingzhou Capital was founded in 2016.
How many portfolio companies does Qingzhou Capital have?
Qingzhou Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Qingzhou Capital's portfolio?
Recent investments visible on Caplight include NeuroXess, Hangzhou Huiwei Intelligent Medical Technology, KingTiger Technology, Hangzhou Huiwei Intelligent Medical Technology, Hangzhou Huiwei Intelligent Medical Technology.
What was Qingzhou Capital's most recent investment?
Qingzhou Capital's most recent investment on Caplight was in NeuroXess in 2022.
What sectors does Qingzhou Capital focus on?
Qingzhou Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, AI, Data & Cloud Infrastructure.
What company stages does Qingzhou Capital focus on?
Stage focus information for Qingzhou Capital is not publicly available.